Insights

Rapid Expansion Neurogene is actively expanding its manufacturing capabilities with new facilities in Houston, Texas, indicating a focus on scaling gene therapy production and increasing capacity to meet growing demand for genetic medicines.

Innovative Monitoring The company’s recent launch of a monitoring and treatment system for AAV gene therapy showcases a commitment to advancing safety and efficacy, presenting opportunities for partnerships in medical devices and supportive technologies.

Significant Investment With over 184 million dollars in funding and a recent 200 million dollar PIPE financing, Neurogene demonstrates strong financial backing, making it a prime target for sales of advanced biotech tools, biotech capital equipment, and research services.

Leadership & Talent The appointment of high-profile executives like the new General Counsel and Chief Medical Officer highlights Neurogene’s focus on strengthening leadership, signaling potential opportunities for executive recruitment, consultancy services, and specialized biotech support.

Focus on Rare Diseases Neurogene’s dedication to developing genetic medicines for rare and devastating neurological disorders suggests potential collaborations with organizations specializing in rare disease diagnostics, patient monitoring, and specialized pharma distribution channels.

Neurogene Inc. Tech Stack

Neurogene Inc. uses 8 technology products and services including SAS, Amazon Web Services, WordPress, and more. Explore Neurogene Inc.'s tech stack below.

  • SAS
    Business Intelligence
  • Amazon Web Services
    Cloud Hosting
  • WordPress
    Content Management System
  • SCADA
    Control Systems
  • SAP
    Customer Relationship Management
  • jQuery Migrate
    Javascript Libraries
  • Ubuntu
    Operating Systems
  • WP Engine
    Platform As A Service

Neurogene Inc.'s Email Address Formats

Neurogene Inc. uses at least 1 format(s):
Neurogene Inc. Email FormatsExamplePercentage
First.Last@neurogene.comJohn.Doe@neurogene.com
96%
First.Middle@neurogene.comJohn.Michael@neurogene.com
2%
Last.First@neurogene.comDoe.John@neurogene.com
1%
FLast@neurogene.comJDoe@neurogene.com
1%

Frequently Asked Questions

Where is Neurogene Inc.'s headquarters located?

Minus sign iconPlus sign icon
Neurogene Inc.'s main headquarters is located at 535 West 24th Street, 5th Floor. The company has employees across 2 continents, including North AmericaEurope.

What is Neurogene Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Neurogene Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Neurogene Inc.'s stock symbol?

Minus sign iconPlus sign icon
Neurogene Inc. is a publicly traded company; the company's stock symbol is NGNE.

What is Neurogene Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Neurogene Inc.'s official website is neurogene.com and has social profiles on LinkedIn.

What is Neurogene Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Neurogene Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Neurogene Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, Neurogene Inc. has approximately 112 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: R. M.Chief Medical Officer: J. C. J.Chief Scientific Officer: S. C.. Explore Neurogene Inc.'s employee directory with LeadIQ.

What industry does Neurogene Inc. belong to?

Minus sign iconPlus sign icon
Neurogene Inc. operates in the Biotechnology Research industry.

What technology does Neurogene Inc. use?

Minus sign iconPlus sign icon
Neurogene Inc.'s tech stack includes SASAmazon Web ServicesWordPressSCADASAPjQuery MigrateUbuntuWP Engine.

What is Neurogene Inc.'s email format?

Minus sign iconPlus sign icon
Neurogene Inc.'s email format typically follows the pattern of First.Last@neurogene.com. Find more Neurogene Inc. email formats with LeadIQ.

How much funding has Neurogene Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, Neurogene Inc. has raised $184M in funding. The last funding round occurred on Dec 16, 2020 for $115M.

When was Neurogene Inc. founded?

Minus sign iconPlus sign icon
Neurogene Inc. was founded in 2018.

Neurogene Inc.

Biotechnology ResearchNew York, United States51-200 Employees

Neurogene is accelerating development of new genetic medicines to people with devastating neurological diseases and their families. To do this, we are working with experts across the globe to advance a broad pipeline of programs to treat the underlying cause of serious neurological disorders and thereby address the overwhelming need for new therapies.

Although the human genome was sequenced for the first time nearly 20 years ago, the true genomics revolution is taking place now, providing us with the ability to radically alter rare, genetic disorders. At Neurogene, we are working to provide medicines to improve the lives of neurologically-impaired and developmentally-delayed children and their families.

We are building a team of passionate, driven individuals who envision a world in which all families have access to genetic medicines, even if the disorder is exceedingly rare. 

To learn more, please visit http://www.neurogene.com/careers/.

Section iconCompany Overview

Headquarters
535 West 24th Street, 5th Floor
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
NGNE
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $184M

    Neurogene Inc. has raised a total of $184M of funding over 2 rounds. Their latest funding round was raised on Dec 16, 2020 in the amount of $115Mas a series B.

  • $50M$100M

    Neurogene Inc.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $184M

    Neurogene Inc. has raised a total of $184M of funding over 2 rounds. Their latest funding round was raised on Dec 16, 2020 in the amount of $115Mas a series B.

  • $50M$100M

    Neurogene Inc.'s revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.